Skip to main content

Table 1 Patient demographics from healthy controls and patients with sarcoidosis included in the current study. Demographics of patients with sarcoidosis according to the presence or absence of Löfgren’s syndrome and X-ray stage are also presented

From: Soluble epoxide hydrolase derived lipid mediators are elevated in bronchoalveolar lavage fluid from patients with sarcoidosis: a cross-sectional study

 

Healthy control

Sarcoidosis

(All patients)

Sarcoidosis non-Löfgren

Sarcoidosis Löfgren

Sarcoidosis

X-ray stage I

Sarcoidosis

X-ray stage II

Number

16

41

20

21

22

19

Age, years

23 [23–25]

40 [33–47]e

43 [33–52]

40 [35–43]

41 [36–48]

40 [32–46]

Sex, female/male

8/8

15/26

7/13

8/13

7/15

8/11

CD4/CD8

1.8 [1.4–2.7]a

8.7 [4.8–11.5]e

7.0 [4.3–11.0]

9.6 [4.9–13.0]

9.7 [5.0–12.6]

7.3 [3.8–11.3]

X-ray stage, I/II

22/19

8/12

14/7

22/0

0/19

%FEV1

111 [101–118]

89 [81–100]e

89 [80–101]

89 [82–100]

88 [81–100]

89 [82–101]

%FVC

114 [109–117]

90 [81–99]b,e

91 [79–101]c

90 [82–96]d

90 [81–97]e

91 [81–100]e

  1. Age, CD4/CD8, %FEV1 and %FVC are presented as median [Interquartile range]
  2. an = 13
  3. bn = 28
  4. cn = 16
  5. dn = 12
  6. ep < 0.05, 2 tailed t-test